Vor Ort
Merkzettel Warenkorb
Produktbild: Management of Muscle Invasive Bladder Cancer
- 12%

Management of Muscle Invasive Bladder Cancer

Aus der Reihe Management of Urology
12% sparen

93,99 € UVP 106,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

04.02.2022

Abbildungen

XXXIX, 590 p. 37 illus. in color.

Verlag

Springer

Seitenzahl

590

Maße (L/B/H)

23,5/15,5/3,4 cm

Gewicht

943 g

Auflage

22001 Auflage 1st ed. 2021

Sprache

Englisch

ISBN

978-3-030-57917-3

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

04.02.2022

Abbildungen

XXXIX, 590 p. 37 illus. in color.

Verlag

Springer

Seitenzahl

590

Maße (L/B/H)

23,5/15,5/3,4 cm

Gewicht

943 g

Auflage

22001 Auflage 1st ed. 2021

Sprache

Englisch

ISBN

978-3-030-57917-3

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Management of Muscle Invasive Bladder Cancer

  • 1. Introduction to muscle invasive bladder cancer.- 2. Epidemiology and risk factors in muscle invasive bladder cancer.- 3. The molecular basis of muscle invasive bladder cancer.- 4. Histological variants in MIBC - squamous cell and squamous differentiation.- 5. Histological variants in muscle invasive bladder cancer – adenocarcinoma.- 6. Histological variants in muscle invasive bladder Cancer - sarcomatoid cancer.- 7. MIBC Carcinosarcoma.- 8. Muscle invasive bladder cancer- small cell.- 9. MIBC plasmacytoid.- 10. MIBC  and micropapillary bladder cancer.- 11. MIBC bladder cancer assessment and diagnosis.- 12. A systematic review on blue light cystoscopy in bladder cancer diagnostics.- 13. A systematic review on the staging conundrum in bladder cancer.- 14. Current state of investigations and limitations in muscle invasive bladder cancer.- 15. Risk stratification in bladder cancer.- 16. Preventative measures for those with high risk MIBC.- 17. Bladder cancer risk post pelvic irradiation.- 18. A systematic review on bladder preservation strategies and MIBC.- 19. Partial cystectomy.- 20. Muscle invasive bladder cancer and neoadjuvant chemotherapy.- 21. Controversies in clinical effectiveness of neoadjuvant chemotherapy.- 22. Trimodal therapy in bladder cancer.- 23. Systematic review on trimodal therapy in bladder cancer.- 24. Trimodal therapy - a systematic review.- 25. Reviews related to trimodal therapy for MIBC.- 26. Radical cystectomy lap open robotic.- 27. Prostate sparing cystectomy - a systematic review.- 28. A systematic review on nerve sparing cystoprostatectomy.- 29. MIBC - orthotopic vs ileal conduit.- 30. MIBC - a systematic review on orthotopic neobladder vs. ileal conduit.- 31. MIBC and radical cystectomy in the elderly.- 32. MIBC radical radiotherapy.- 33. MIBC - quality of life with urinary diversion.- 34. Neoadjuvant chemotherapy for muscle invasive bladder cancer.- 35. Muscle invasive bladder cancer and the staging conundrum.- 36. Radical cystectomy outcomes.- 37. Muscle Invasive bladder cancer and neoadjuvant chemotherapy.- 38. Muscle invasive bladder cancer and the staging conundrum.- 39. Physical pre-habilitation prior to radical cystectomy.- 40. Exercise therapy pre surgery.- 41. Patient fitness for surgery.- 42. CPEX testing prior to major urological surgery.- 43. Cardio-pulmonary exercise testing and major urological surgery.- 44. Robotic radical cystectomy and enhanced recovery.- 45. The robotic approach to redo surgery.- 46. Robotic cystectomy and intracorporeal neobladder formation.- 47. Secondary pelvic malignancies and bladder cancer.- 48. Organ sparing cystectomy.- 49. Robotic radical cystectomy.- 50. Robotic cystectomy and intracorporeal stoma formation.- 51. Orthotopic neobladders vs. ileal conduits.- 52. The role of enhanced recovery in robotic cystectomy.- 53. Robotic radical cystectomy and lymph node dissection.- 54. Robotic cystectomy and sentinel node mapping.- 55. Robotic radical cystectomy and intracorporeal stoma formation.- 56. Lap vs open vs robotic cystectomy.- 57. A systematic review on obesity in bladder cancer.- 58. Systematic review results on obesity in bladder cancer.- 59. Reviews on BMI and bladder cancer.- 60. Survivorship Issues in muscle invasive bladder cancer.- 61. Muscle invasive bladder cancer and health related quality of life.- 62. Body image in bladder cancer.- 63. The rationale for neoadjuvant chemotherapy.- 64. Support for partners in bladder cancer.